Annis Gardner Whiting Capital Advisors LLC Invests $75,000 in Corteva, Inc. (NYSE:CTVA)

Annis Gardner Whiting Capital Advisors LLC bought a new position in Corteva, Inc. (NYSE:CTVAFree Report) in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm bought 1,474 shares of the company’s stock, valued at approximately $75,000.

Several other hedge funds and other institutional investors have also modified their holdings of the business. HighTower Advisors LLC boosted its position in shares of Corteva by 7.7% in the third quarter. HighTower Advisors LLC now owns 275,961 shares of the company’s stock worth $14,116,000 after buying an additional 19,651 shares during the period. Pathstone Family Office LLC raised its holdings in shares of Corteva by 594.5% during the third quarter. Pathstone Family Office LLC now owns 70,895 shares of the company’s stock worth $3,627,000 after acquiring an additional 60,687 shares in the last quarter. Van ECK Associates Corp raised its holdings in shares of Corteva by 78.7% during the third quarter. Van ECK Associates Corp now owns 7,645,091 shares of the company’s stock worth $391,123,000 after acquiring an additional 3,366,106 shares in the last quarter. Charles Schwab Investment Management Inc. raised its holdings in shares of Corteva by 1.3% during the third quarter. Charles Schwab Investment Management Inc. now owns 4,070,089 shares of the company’s stock worth $208,226,000 after acquiring an additional 53,991 shares in the last quarter. Finally, Sequoia Financial Advisors LLC raised its holdings in shares of Corteva by 4.0% during the third quarter. Sequoia Financial Advisors LLC now owns 13,319 shares of the company’s stock worth $681,000 after acquiring an additional 510 shares in the last quarter. Institutional investors and hedge funds own 80.56% of the company’s stock.

Corteva Trading Up 0.7 %

Corteva stock opened at $53.59 on Friday. Corteva, Inc. has a 52 week low of $43.22 and a 52 week high of $64.98. The firm has a market capitalization of $37.77 billion, a PE ratio of 52.54, a PEG ratio of 1.36 and a beta of 0.73. The business’s 50-day simple moving average is $47.23 and its 200-day simple moving average is $49.19. The company has a debt-to-equity ratio of 0.09, a quick ratio of 0.90 and a current ratio of 1.56.

Corteva (NYSE:CTVAGet Free Report) last released its earnings results on Thursday, February 1st. The company reported $0.15 earnings per share for the quarter, topping analysts’ consensus estimates of $0.06 by $0.09. Corteva had a return on equity of 7.43% and a net margin of 4.27%. The business had revenue of $3.71 billion for the quarter, compared to the consensus estimate of $3.54 billion. During the same period last year, the business earned $0.16 earnings per share. Equities research analysts forecast that Corteva, Inc. will post 2.87 earnings per share for the current year.

Corteva Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, March 15th. Shareholders of record on Friday, March 1st will be issued a dividend of $0.16 per share. This represents a $0.64 dividend on an annualized basis and a yield of 1.19%. The ex-dividend date is Thursday, February 29th. Corteva’s payout ratio is 62.75%.

Insider Buying and Selling at Corteva

In related news, insider Samuel R. Eathington acquired 1,094 shares of the firm’s stock in a transaction on Tuesday, November 28th. The shares were bought at an average cost of $46.07 per share, with a total value of $50,400.58. Following the completion of the acquisition, the insider now owns 41,066 shares of the company’s stock, valued at $1,891,910.62. The acquisition was disclosed in a filing with the SEC, which is accessible through the SEC website. In other Corteva news, insider Samuel R. Eathington bought 1,094 shares of Corteva stock in a transaction dated Tuesday, November 28th. The shares were acquired at an average cost of $46.07 per share, with a total value of $50,400.58. Following the acquisition, the insider now directly owns 41,066 shares of the company’s stock, valued at $1,891,910.62. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Robert D. King bought 640 shares of Corteva stock in a transaction dated Tuesday, November 14th. The stock was acquired at an average cost of $46.77 per share, for a total transaction of $29,932.80. Following the completion of the acquisition, the executive vice president now directly owns 59,701 shares in the company, valued at $2,792,215.77. The disclosure for this purchase can be found here. Over the last ninety days, insiders have purchased 2,084 shares of company stock valued at $95,527. 0.14% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

Several analysts recently issued reports on CTVA shares. Mizuho cut their price objective on Corteva from $59.00 to $56.00 and set a “buy” rating for the company in a report on Thursday, February 1st. Morgan Stanley cut their price objective on Corteva from $80.00 to $60.00 and set an “overweight” rating for the company in a report on Friday, November 10th. Oppenheimer increased their price objective on Corteva from $60.00 to $62.00 and gave the stock an “outperform” rating in a report on Friday, February 2nd. The Goldman Sachs Group cut their target price on Corteva from $65.00 to $56.00 and set a “neutral” rating on the stock in a report on Tuesday, October 24th. Finally, Berenberg Bank lowered Corteva from a “buy” rating to a “hold” rating and cut their target price for the company from $63.00 to $52.00 in a report on Monday, November 27th. Five research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $62.84.

Check Out Our Latest Stock Report on CTVA

Corteva Profile

(Free Report)

Corteva, Inc operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics.

Recommended Stories

Want to see what other hedge funds are holding CTVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Corteva, Inc. (NYSE:CTVAFree Report).

Institutional Ownership by Quarter for Corteva (NYSE:CTVA)

Receive News & Ratings for Corteva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corteva and related companies with MarketBeat.com's FREE daily email newsletter.